BLUE BIOFUELS, INC.
Data quality: 83%
BIOF
OTC
Manufacturing
Chemicals
$0.15
▼
$0.00
(-1.95%)
Mkt Cap: 48.37 M
Price
$0.15
Mkt Cap
48.37 M
Day Range
$0.15 — $0.15
52-Week Range
$0.10 — $0.22
Volume
80,000
Open $0.15
50D / 200D Avg
$0.17
10.23% below
50D / 200D Avg
$0.17
13.66% below
Quick Summary
Key Takeaways
Negative free cash flow of -913,900.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.04
Interest CoverageN/A
Valuation
PE (TTM)
-16.83
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -16.8 | -2.0 |
| P/B | — | 5.1 |
| ROE % | — | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -2.87 M |
| ROE | N/A | ROA | -195.92% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -913,900.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.04 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -2.29 M | Tangible Book Value | -3.06 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -16.83 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -1.89% | ||
| Market Cap | 48.37 M | Enterprise Value | 48.27 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.01 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 31.79% |
| SBC-Adj. FCF | -1.75 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -2.87 M | -1.42 M | -3.06 M | -3.96 M | -2.14 M |
| EPS (Diluted) | -0.01 | -0.01 | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -3.72 M | -4.06 M | -3.19 M | -3.93 M | -2.17 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 2.31 M | 2.33 M | 1.85 M | 2.35 M | 1.10 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 145,852.0 | 118,798.0 | 216,785.0 | 138,464.0 | 131,715.0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.41 M | 1.39 M | 1.03 M | 1.11 M | 1.84 M |
| Total Liabilities | 5.11 M | 4.24 M | 4.59 M | 3.46 M | 3.23 M |
| Shareholders' Equity | -3.71 M | -2.85 M | -3.56 M | -2.36 M | -1.40 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 65,200.0 | 48,797.0 | 41,008.0 | 211,901.0 | 1.16 M |
| Current Assets | 76,751.0 | 81,286.0 | 76,758.0 | 255,020.0 | 1.21 M |
| Current Liabilities | 2.98 M | 2.21 M | 1.50 M | 638,721.0 | 496,161.0 |
{"event":"ticker_viewed","properties":{"ticker":"BIOF","listing_kind":"stock","pathname":"/stocks/biof","exchange":"OTC","country":"US"}}